Russell Investments Group Ltd. increased its position in Lifevantage Corporation (NASDAQ:LFVN - Free Report) by 393,513.8% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 114,148 shares of the company's stock after acquiring an additional 114,119 shares during the period. Russell Investments Group Ltd. owned about 0.91% of Lifevantage worth $1,664,000 at the end of the most recent reporting period.
A number of other hedge funds also recently added to or reduced their stakes in LFVN. Brown Advisory Inc. purchased a new position in Lifevantage in the 1st quarter worth approximately $150,000. Cannon Global Investment Management LLC purchased a new stake in Lifevantage during the 1st quarter valued at $156,000. XTX Topco Ltd purchased a new stake in Lifevantage during the 1st quarter valued at $186,000. Cambridge Investment Research Advisors Inc. raised its stake in Lifevantage by 23.2% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 12,867 shares of the company's stock valued at $188,000 after buying an additional 2,421 shares during the last quarter. Finally, Schonfeld Strategic Advisors LLC purchased a new stake in Lifevantage during the 4th quarter valued at $282,000. 35.32% of the stock is currently owned by hedge funds and other institutional investors.
Lifevantage Price Performance
LFVN remained flat at $13.10 during mid-day trading on Friday. 139,266 shares of the company's stock were exchanged, compared to its average volume of 88,896. The firm has a market cap of $164.93 million, a PE ratio of 18.99 and a beta of 0.45. The stock's 50-day moving average is $13.07 and its two-hundred day moving average is $13.86. Lifevantage Corporation has a 1-year low of $7.09 and a 1-year high of $27.38.
Lifevantage Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 16th. Shareholders of record on Monday, September 8th will be paid a dividend of $0.045 per share. The ex-dividend date is Monday, September 8th. This represents a $0.18 dividend on an annualized basis and a yield of 1.4%. Lifevantage's payout ratio is currently 26.09%.
Insiders Place Their Bets
In other Lifevantage news, CFO Carl Aure sold 2,746 shares of the business's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $13.39, for a total transaction of $36,768.94. Following the completion of the sale, the chief financial officer directly owned 133,303 shares in the company, valued at approximately $1,784,927.17. The trade was a 2.02% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 20.65% of the company's stock.
About Lifevantage
(
Free Report)
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
Further Reading
Before you consider Lifevantage, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lifevantage wasn't on the list.
While Lifevantage currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
